Platelets and ductus arteriosus closure in neonates

Semin Perinatol. 2023 Mar;47(2):151719. doi: 10.1016/j.semperi.2023.151719. Epub 2023 Mar 1.

Abstract

Platelet plug formation is critically involved in murine ductus arteriosus closure and thrombocytopenia in preterm infants seems to negatively affect spontaneous and pharmacologically induced ductal closure. Furthermore, platelet dysfunction may contribute to ductal patency, especially in extremely immature infants. Neonatal platelets likely have multifaceted roles during ductal closure, such as secretion of several signaling molecules and facilitation of specific cell-cell interactions. The only available randomized-controlled trial on platelet transfusions in preterm infants with patent ductus arteriosus demonstrated that a liberal transfusion regimen did not promote ductal closure, but was associated with an increased rate of intraventricular hemorrhage. Herein, we discuss the available mechanistic evidence on the role of platelets in ductus arteriosus closure and their potential clinical implications in preterm infants. We further briefly outline future research directions aimed at a better understanding of platelet-endothelial interactions in neonatal health and disease.

Keywords: Ibuprofen; Indomethacin; Patent ductus arteriosus; Platelets; Preterm infant; Thrombocytopenia; Very low birth weight.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Animals
  • Cyclooxygenase Inhibitors / therapeutic use
  • Ductus Arteriosus*
  • Ductus Arteriosus, Patent* / drug therapy
  • Humans
  • Ibuprofen / therapeutic use
  • Indomethacin / therapeutic use
  • Infant
  • Infant, Extremely Premature
  • Infant, Newborn
  • Mice

Substances

  • Indomethacin
  • Cyclooxygenase Inhibitors
  • Ibuprofen